W 906 (Ranitidine 150 mg)

Pill imprint W 906 has been identified as Ranitidine hydrochloride 150 mg.

Ranitidine is used in the treatment of gerd; erosive esophagitis; gastric ulcer maintenance treatment; zollinger-ellison syndrome; duodenal ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for W 906

Ranitidine hydrochloride 150 mg W 906
Ranitidine hydrochloride
Imprint:
W 906
Strength:
150 mg
Color:
White
Size:
11.00 mm
Shape:
Six-sided
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Wockhardt USA
National Drug Code (NDC):
64679-0906
Inactive Ingredients:
microcrystalline cellulose
croscarmellose sodium
magnesium silicate
silicon dioxide colloidal
magnesium stearate
castor oil
hypromellose
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
63304-0838 Ranbaxy Pharmaceuticals Inc.
54569-4507 A S Medication Solutions LLC (repackager)
68115-0314 Dispensexpress Inc (repackager)
58016-0345 Southwood Pharmaceuticals Inc (repackager)
33261-0099 Aidarex Pharmacuticals LLC (repackager)
53002-0552 Pharmedix (repackager)
67544-0483 Prepak Systems Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)